CA: A Cancer Journal for Clinicians

Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Wiley, CSA, Highwire from 1950, Gale, Proquest, and Wiley from 1997

  1. Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening.

    CA: A Cancer Journal for Clinicians 59(1):27 (2009) PMID 19147867

    Each year, the American Cancer Society (ACS) publishes a report summarizing its recommendations for early cancer detection, data and trends in cancer screening rates, and select issues related to cancer screening. In 2008, the ACS, the American Gastroenterological Association, the American Colle...
    PDF not found
  2. Advances in understanding and management of myeloproliferative neoplasms.

    CA: A Cancer Journal for Clinicians 59(3):171 (2009) PMID 19369682

    According to the 2008 World Health Organization classification system for hematologic malignancies, the myeloproliferative neoplasms (MPN) include chronic myelogenous leukemia, polycythemia vera, essential thrombocythemia, primary myelofibrosis, mastocytosis, chronic eosinophilic leukemia-not ot...
    PDF not found
  3. Cancer statistics, 2009.

    CA: A Cancer Journal for Clinicians 59(4):225 (2009) PMID 19474385

    Each year, the American Cancer Society estimates the number of new cancer cases and deaths expected in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival based on incidence data from the National Cancer Institute, Centers for Dise...
    PDF not found
  4. Prostate cancer: current evidence weighs against population screening.

    CA: A Cancer Journal for Clinicians 59(4):220 (2009) PMID 19564244

    PDF not found
  5. Infectious diseases and global cancer control.

    CA: A Cancer Journal for Clinicians 59(1):5 (2009) PMID 19147864

    PDF not found
  6. Lymph node evaluation as a colon cancer quality measure.

    CA: A Cancer Journal for Clinicians 59(1):2 (2009) PMID 19147863

    PDF not found
  7. Many women treated with chest radiotherapy for childhood cancers are not getting mammograms as recommended by guidelines.

    CA: A Cancer Journal for Clinicians 59(3):141 (2009) PMID 19369681

    PDF not found
  8. Screening for prostate cancer.

    CA: A Cancer Journal for Clinicians 59(4):264 (2009) PMID 19564245

    In the United States, prostate cancer will affect 1 man in 6 during his lifetime. Since the mid-1980s, screening with the prostate-specific antigen (PSA) blood test has more than doubled the risk of a prostate cancer diagnosis. A decrease in prostate cancer death rates has been observed since th...
    PDF not found
  9. Local surgical, ablative, and radiation treatment of metastases.

    CA: A Cancer Journal for Clinicians 59(3):145 (2009) PMID 19364702

    Because local therapies directed toward a specific tumor mass are known to be effective for treating early-stage cancers, it should be no surprise that there has been considerable historical experience using local therapies for metastatic disease. In more recent years, increasing interest in the...
    PDF not found
  10. Earlier use of aggressive therapy could prevent one-third of bladder cancer deaths.

    CA: A Cancer Journal for Clinicians 59(3):142 (2009) PMID 19369683

    PDF not found
  11. Promoting colorectal cancer screening: which interventions work?

    CA: A Cancer Journal for Clinicians 59(4):215 (2009) PMID 19542494

    PDF not found
  12. Cutaneous manifestations of internal malignancy.

    CA: A Cancer Journal for Clinicians 59(2):73 (2009) PMID 19258446

    The skin often mirrors changes in the organism it envelops. Many neoplastic diseases that affect internal organs display cutaneous manifestations, which may be the presenting signs and symptoms of the underlying malignancy. These may reflect direct involvement of the skin by the tumor (ie, tumor...
    PDF not found
  13. Lymphedema.
    Author(s) unavailable

    CA: A Cancer Journal for Clinicians 59(1):25 (2009) PMID 19147866

    PDF not found
  14. Patient adherence and persistence with oral anticancer treatment.

    CA: A Cancer Journal for Clinicians 59(1):56 (2009) PMID 19147869

    Given the recent significant increase in the use of oral therapies in cancer management, an understanding of patients' adherence to and persistence with oral therapy is crucial. Nonadherence and early cessation may be substantial barriers to the delivery of valuable therapies, and may impair hea...
    PDF not found
  15. Novel agents on the horizon for cancer therapy.

    CA: A Cancer Journal for Clinicians 59(2):111 (2009) PMID 19278961

    Although cancer remains a devastating diagnosis, several decades of preclinical progress in cancer biology and biotechnology have recently led to successful development of several biological agents that substantially improve survival and quality of life for some patients. There is now a rich pip...
    PDF not found
  16. Lymphedema: a primer on the identification and management of a chronic condition in oncologic treatment.

    CA: A Cancer Journal for Clinicians 59(1):8 (2009) PMID 19147865

    The primary goals of oncologic therapy are the compassionate care of cancer patients, eradication of disease, and palliation of symptoms. Advances in various targeted therapies such as highly conformal and image-guided radiotherapy techniques, sentinel lymph node dissection, and molecularly targ...
    PDF not found
  17. Thyroid aspiration cytology: current status.

    CA: A Cancer Journal for Clinicians 59(2):99 (2009) PMID 19278960

    In the adult population, thyroid nodules are common and are increasingly detected by ultrasound examination or other scanning techniques. Depending on their size and ultrasonographic features, these nodules may require further investigation, including tissue diagnosis. Fine-needle aspiration (FN...
    PDF not found
  18. Pharmacogenetics and pharmacogenomics of anticancer agents.

    CA: A Cancer Journal for Clinicians 59(1):42 (2009) PMID 19147868 PMCID PMC3109906

    Large interindividual variation is observed in both the response and toxicity associated with anticancer therapy. The etiology of this variation is multifactorial, but is due in part to host genetic variations. Pharmacogenetic and pharmacogenomic studies have successfully identified genetic vari...
  19. Family physicians and referrals of low-risk women for BRCA1/2 genetic services.

    CA: A Cancer Journal for Clinicians 59(2):70 (2009) PMID 19258448

    PDF not found
  20. Making difficult discussions easier: using prognosis to facilitate transitions to hospice.

    CA: A Cancer Journal for Clinicians 59(4):250 (2009) PMID 19535791

    Patients with advanced cancer face difficult decisions regarding their treatment, and many will need to make difficult choices about end-of-life care because although cancer-directed therapies are increasingly available, few provide a cure. High-quality cancer care includes access to palliative ...
    PDF not found